Betsy Nguyen, MD, is a board-certified cataract and glaucoma specialist with over two decades of experience dedicated to preserving and restoring vision. She trained at the internationally acclaimed Jules Stein Eye Institute at UCLA, where she developed a deep expertise in advanced glaucoma and cataract management. Her commitment to research led her to the USC Doheny Eye Institute, where she contributed to pioneering advancements in glaucoma care.
Graduating at the top of her class from the UCLA School of Medicine with the highest distinction, Dr. Nguyen continued her specialization at the University of California, San Francisco (UCSF), completing a prestigious fellowship in glaucoma. A recognized leader in her field, she is a diplomate of the American Academy of Ophthalmology and the California Academy of Eye Physicians & Surgeons. Her reputation for clinical excellence earned her the distinguished role of team eye doctor for the Los Angeles Angels and the Anaheim Ducks.
Dr. Nguyen has devoted her career to advancing the understanding and treatment of cataracts and glaucoma, two conditions that often coexist and require an integrated approach for optimal patient outcomes. She actively participates in FDA clinical trials, furthering advancements in glaucoma and cataract treatments, ensuring that her patients benefit from the most cutting-edge technologies available. By leveraging the latest surgical innovations and evidence-based treatment strategies, she ensures that her patients receive the most advanced, customized care available.
Beyond her clinical practice, Dr. Nguyen is a passionate researcher dedicated to expanding treatment options for glaucoma patients. She has led multiple clinical studies and has published extensively in peer-reviewed journals. Her work has influenced modern approaches to glaucoma treatment, including the combined management of cataracts and glaucoma using cutting-edge surgical techniques.
Recognized for her unwavering dedication to patient care, Dr. Nguyen believes in a highly personalized approach, taking the time to understand each patient’s unique vision needs. “I treat every patient as if they were my own family, providing the highest level of attention and surgical excellence to help them achieve their best possible vision.”
1991 Bachelor of Science, Biological Sciences, University of California, Irvine, CA
1995 Doctor of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA
1995-1996 Internship, Preliminary Medicine, University of California, San Fernando Valley, CA
1996-1999 Residency, Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, CA
1999-2000 Clinical Fellowship, Glaucoma and Clinical Instructor; University of California, San Francisco, CA
and California Pacific Medical Center
1997 Medical Board of California
2000 American Board of Ophthalmology
American Academy of Ophthalmology
American Society of Cataract and Refractive Surgery
American Medical Association
California Medical Association
California Academy of Eye Physicians & Surgeons
Memorial Physician Society
Orange County Ophthalmology Society
Orange County Glaucoma Society
2018 -Present Principle Investigator, Glaukos Travaprost IDose Phase 3 Clinical Study
2017 -2018 Sub-Investigator, CyPass Post-Approval Clinical Study
2013 Researcher for USC – Collaboration with Chinese American Eye Study (CHES). Collaborate with Rohit Varma, MD.
2012 Baseline risk factors that predict the development of open-angle glaucoma in a population: The Los Angeles Latino Eye Study. Ophthalmology. 2012 Nov;19(11):2245-53.
2012 Four-year incidence of open-angle glaucoma and ocular hypertension: The Los Angeles Latino Eye Study. Am J Ophthalmol. 2012 Aug;154(2):315-325.
2011 “Population and High Risk Group Screening for Glaucoma: The Los Angeles Latino Eye Study”, Invest Ophthalmol Vis Sci. 2011 August; 52(9): 6257–6264.
2000-2011 Researcher for USC – Collaboration with Los Angeles Latino Eye Study (LALES). Collaborate with Rohit Varma, MD and Brian Francis, MD.
2005 Screening for Glaucomatous Optic Nerve Damage: The Los Angeles Latino Eye Study. ARVO Abstract. Invest Ophthalmol Vis Sci 2005;46: E-Abstract 2499.
2004 “Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study,” Ophthalmology, 2004 Aug; 111(8):1439-48.
2003 Prevalence of Open-Angle Glaucoma and Ocular Hypertension in Latinos. The Los Angeles Latino Eye Study (LALES). ARVO Abstract. Invest Ophthalmol Vis Sci 2003;44: E-Abstract 317
2007-2009 Schering study (LOCS III Certified)
2004-2006 TAKEDA study (LOCS III Certified)
2003 Advanced Glaucoma Training DVD, for Allergan
1999-2000 Evaluation of computerized optic discs to determine stability vs. progression of glaucoma, under Robert L. Stamper, MD, Chief of Glaucoma, UCSF.
1998-1999 Retrospective longitudinal study of progression of glaucoma, using multivariate analysis of serial visual fields, stereoscopic disc photographs, and confocal laser imaging, under Joseph Caprioli, MD, Chief of Glaucoma, UCLA Jules Stein Eye Institute. ARVO paper presentation, “Identification of Glaucoma Progression Through Combined Use of Quantitative Structural and Functional Measures,” May 1999.
1995-1997 Development of quantitative methods for evaluation of socket motility of orbital implants, under Robert A. Goldberg, MD, Chief of Oculoplastics, UCLA Jules Stein Eye Institute. Poster presentation, Jules Stein Eye Institute Research and Alumni Day, 1998.
1992-1993 Investigation of traumatic optic neuropathy in a rat model, under Robert A. Goldberg, MD & Kenneth Steinsapir, MD, UCLA School of Medicine. Poster presentation, “Dynamic Changes in Cerebral Glucose Metabolism Following Optic Nerve Trauma,” at Neuroscience, 1992.
1989-1991 Investigation of the effects of glycation on the function of the sodium-potassium pump, under Margaret H. Garner, PhD, UCI School of Medicine. Publication, “Na,K-ATPase of Cultured Bovine Lens Epithelial Cells: H2O2 Effects,” Experimental Eye Research,
1992 Mar, 54 (3): 321-7. Poster presentation, “Glucose Control, by Nonenzymatic Glycation of Na, K-ATPase Function in the Nondiabetic,” FASEB 1991.